Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 229 (6%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3283 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALENDRONATE/VITAMIN D3 70MG 5600UNIT TABLET Resolved 2017-11-27 2018-07-03 30793
APO-ALENDRONATE/VITAMIN D3 70MG 5600UNIT TABLET Resolved 2018-11-27 2019-01-03 67708
APO-ALENDRONATE/VITAMIN D3 70MG 5600UNIT TABLET Resolved 2020-11-26 2021-04-15 128922
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2021-06-11 2021-08-03 140767
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2023-02-16 2023-04-21 185033
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2023-05-06 2023-06-16 191892
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-18 28534
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-08-07 121322
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-18 2021-01-20 131809
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-09-01 202830
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2023-12-15 209372
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-12 2024-03-22 215973
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-19 2024-06-28 225779
APO-ALLOPURINOL 300MG TABLET Resolved 2019-01-30 2019-02-13 74014
APO-ALLOPURINOL 100MG TABLET Resolved 2020-02-13 2020-04-23 105988

Showing 221 to 240 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO TRIAZIDE 50MG 25MG TABLET Discontinued 2018-09-08 2019-02-13 60837
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH 500MG TABLET Discontinued 2018-09-07 2018-09-08 60157
APO-ALENDRONATE 10MG TABLET To be discontinued 2018-09-07 2019-12-20 60163
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2025-01-10 2025-01-11 247462
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2025-01-10 2025-01-11 247466
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2025-01-10 2025-01-27 247469
APO-AMITRIPTYLINE 75MG TABLET To be discontinued 2025-01-10 2025-01-10 247472

Showing 41 to 60 of 366